Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Pets at Home cuts FY profit guidance on subdued retail market

(Sharecast News) - Pets at Home cut its full-year profit guidance on Thursday, pointing to "subdued" retail market growth rates. In its FY25 results, Pets set its FY26 guidance based around an assumption of 2% growth in the pet retail market. It said on Thursday that while this scenario assumed improving growth through the year, the market growth rates in the first quarter have been below those initial expectations.

It now expects market growth of around 1% and has adjusted its guidance to reflect this. As a result, Pets cut its full-year underlying pre-tax profit range to between £110m and £120m, from previous guidance of £115m to £125m.

"Where we end up in our updated range is mostly dependent on the trajectory of retail market growth through the second half of FY26," it said.

"Reaching the top end of guidance would require a step up in market growth, while the bottom end of guidance would imply a continuation of current subdued market trends through the remainder of the year."

The group said that against this subdued market backdrop, it was "pleased" to have delivered sequential improvement in its relative performance and continues to expect it will outperform the retail market over FY26.

In the 16 weeks to 17 July, consumer revenue rose 0.4% to £591m. Vet Group revenue was up 7.1%, driven by higher average transaction value and increased numbers of Care Plans.

Meanwhile, retail consumer revenue declined 3%, with sequential improvement, as the company moved beyond the transition of online sales to Stafford DC, and delivered against a subdued market backdrop with no growth in the pet retail market.

Group statutory revenue fell 1.9% to £435m, with group like-for-like revenue down 1.9%.

Vet Group revenue grew 6.2%, with LFL growth of 7.8%, reflecting strong consumer revenue growth and continued progress in converting company-owned practices into Joint Venture practices.

Retail revenue declined 3.0% year-on-year, with LFL sales down 3%.

Chief executive Lyssa McGowan said: "We are pleased to have seen momentum in our business build through Q1, against a subdued market backdrop and uncertain consumer environment.

"Progress has been made across all 4 of our strategic metrics in the quarter, including growing our subscription revenues by over 40%, growing Pets Club members, increasing average spend and continuing to grow our Vet talent as we continue building the world's best pet care platform."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.